{
  "id": "LSB10364",
  "type": "CRS Report Type LSB",
  "typeId": "LSB",
  "number": "LSB10364",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "Reducing Harm or Enabling Substance Abuse? Supervised Injection Sites Under Federal Drug Law",
      "retrieved": "2020-09-07T12:24:55.700210",
      "id": "LSB10364_1_2019-11-22",
      "formats": [
        {
          "filename": "files/2019-11-22_LSB10364_f22f2138b743eb3f35b48d82d0e339d4751ac0b1.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/LSB/LSB10364/1",
          "sha1": "f22f2138b743eb3f35b48d82d0e339d4751ac0b1"
        },
        {
          "format": "HTML",
          "filename": "files/2019-11-22_LSB10364_f22f2138b743eb3f35b48d82d0e339d4751ac0b1.html"
        }
      ],
      "date": "2019-11-22",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "LSB",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=LSB10364",
      "type": "CRS Report Type LSB"
    }
  ],
  "topics": []
}